The AFR had some comments on the CSL share price. There appear to be the following drivers
a) Baxter had to slow down the release of a competitive product to CSL's products. So CSL is keeping market share.
b) Octopharma is struggling to get back into the market and win market share, so CSL's market share is being maintained.
c) The share buyback may have soaked up all the shares that people trade (I have lots of CSL in my SMSF and I am not selling - how many others like me?) I have noticed that the sp rise is being driven on low volume.
HT1
what the hell's going on with csl?, page-10
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$294.88 |
Change
1.180(0.40%) |
Mkt cap ! $142.5B | |||
| Open | High | Low | Value | Volume |
| $294.99 | $296.49 | $293.82 | $249.0M | 844.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 347 | $294.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $294.89 | 956 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |